Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Year in Review
  • Published:

CVD prevention in 2014

Advances in the prevention of cardiovascular disease

Nature Reviews Cardiology volume 12, pages 71–73 (2015)Cite this article

Subjects

Prevention of cardiovascular diseases (CVDs), particularly atherosclerosis, remains a priority on the global health agenda. A healthy lifestyle at both individual and population levels, combined with pharmacological treatment of CVD risk factors, is recommended. In this Year in Review article, we discuss the major advances in CVD prevention in 2014.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Five combined low-risk behaviours and the population-preventable proportions of myocardial infarction.

References

  1. Stone, N. J. et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 1, 2889–2934 (2014).

    Article  Google Scholar 

  2. Saposnik, G. Guideline-directed low-density lipoprotein management in high-risk patients with ischemic stroke: findings from Get With The Guidelines—Stroke 2003 to 2012. Stroke 45, 3343–3351 (2014).

    Article  CAS  Google Scholar 

  3. Pope, C. A. et al. Relationships between fine particulate air pollution, cardiometabolic disorders and cardiovascular mortality. Circ. Res. http://dx.doi.org/10.1161/CIRCRESAHA.116.305060.

  4. Wong, N. D. Epidemiological studies of CHD and the evolution of preventive cardiology. Nat. Rev. Cardiol. 11, 276–289 (2014).

    Article  Google Scholar 

  5. Van Buren, D. J. & Tibbs, T. L. Lifestyle interventions to reduce diabetes and cardiovascular disease risk among children. Curr. Diab. Rep. 14, 557 (2014).

    Article  Google Scholar 

  6. Akesson, A., Larsson, S. C., Discacciati, A. & Wolk, A. Low-risk diet and lifestyle habits in the primary prevention of myocardial infarction in men: a population-based prospective cohort study. J. Am. Coll. Cardiol. 64, 1299–1306 (2014).

    Article  Google Scholar 

  7. Chrysant, S. G. & Chrysant, G. S. Future of polypill use for the prevention of cardiovascular disease and strokes. Am. J. Cardiol. 114, 641–645 (2014).

    Article  Google Scholar 

  8. Bittencourt, M. S. et al. Polypill therapy, subclinical atherosclerosis, and cardiovascular events Implications for the use of preventive pharmacotherapy: MESA (Multi-Ethnic Study of Atherosclerosis). J. Am. Coll. Cardiol. 63, 434–443 (2014).

    Article  Google Scholar 

  9. Kotseva, K. et al. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high risk subjects in general practice: cross-sectional survey in 12 European countries. Eur. J. Cardiovasc. Prev. Rehabil. 17, 530–540 (2010).

    Article  Google Scholar 

  10. Jennings, C. et al. Effectiveness of a preventive cardiology programme for high CVD risk persistent smokers: the EUROACTION PLUS varenicline trial. Eur. Heart J. 35, 1411–1420 (2014).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

N.S. is affiliated faculty at the School of Population & Public Health, University of British Columbia, Vancouver, BC, Canada.

Author information

Authors and Affiliations

  1. Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, PO Box 81465-1148, Isfahan, Iran

    Nizal Sarrafzadegan

  2. Canadian Cancer Society, School of Population & Public Health, University of British Columbia, Room 138–2206 East Mall, Vancouver, V6T 1Z3, BC, Canada

    Carolyn Gotay

Authors
  1. Nizal Sarrafzadegan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carolyn Gotay
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nizal Sarrafzadegan.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sarrafzadegan, N., Gotay, C. Advances in the prevention of cardiovascular disease. Nat Rev Cardiol 12, 71–73 (2015). https://doi.org/10.1038/nrcardio.2014.209

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2014.209

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing